Your browser doesn't support javascript.
loading
ESMO-Magnitude of Clinical Benefit Scale for haematological malignancies (ESMO-MCBS:H) version 1.0.
Kiesewetter, B; Dafni, U; de Vries, E G E; Barriuso, J; Curigliano, G; González-Calle, V; Galotti, M; Gyawali, B; Huntly, B J P; Jäger, U; Latino, N J; Malcovati, L; Oosting, S F; Ossenkoppele, G; Piccart, M; Raderer, M; Scarfò, L; Trapani, D; Zielinski, C C; Wester, R; Zygoura, P; Macintyre, E; Cherny, N I.
Afiliação
  • Kiesewetter B; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
  • Dafni U; Laboratory of Biostatistics, School of Health Sciences, National and Kapodistrian University of Athens, Athens; Frontier Science Foundation-Hellas, Athens, Greece.
  • de Vries EGE; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Barriuso J; The Christie NHS Foundation Trust and Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
  • Curigliano G; European Institute of Oncology, IRCCS, Division of Early Drug Development, Milan; Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy.
  • González-Calle V; Servicio de Hematología, Hospital Universitario de Salamanca-IBSAL, CIBERONC and Centro de Investigación del Cáncer-IBMCC (USAL-CSIC), Salamanca, Spain.
  • Galotti M; ESMO Head Office, Lugano, Switzerland.
  • Gyawali B; Departments of Oncology, Oncology; Public Health Sciences, Queen's University, Kingston; Division of Cancer Care and Epidemiology, Queen's University, Kingston, Canada.
  • Huntly BJP; Cambridge Stem Cell Institute, Department of Haematology, University of Cambridge & Cambridge University Hospitals, Cambridge, UK.
  • Jäger U; Department of Medicine I, Clinical Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.
  • Latino NJ; ESMO Head Office, Lugano, Switzerland.
  • Malcovati L; Department of Molecular Medicine, University of Pavia, Pavia; Department of Hematology Oncology, IRCCS S. Matteo Hospital Foundation, Pavia, Italy.
  • Oosting SF; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Ossenkoppele G; Department of Haematology, VU University Medical Center, Amsterdam, The Netherlands.
  • Piccart M; Institut Jules Bordet, Hôpital Universitaire de Bruxelles (HUB), Université Libre de Bruxelles (ULB), Brussels, Belgium.
  • Raderer M; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
  • Scarfò L; Strategic Research Program on CLL, Università Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele, Milan, Italy.
  • Trapani D; European Institute of Oncology, IRCCS, Division of Early Drug Development, Milan; Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy.
  • Zielinski CC; Wiener Privatklinik, Central European Academy Cancer Center, Vienna, Austria.
  • Wester R; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Zygoura P; Frontier Science Foundation-Hellas, Athens, Greece.
  • Macintyre E; Onco-hématologie Biologique, AP-HP, Necker-Enfants Malades Hospital, Paris; Université Paris Cité, INSERM, CNRS, INEM F-75015, Paris, France.
  • Cherny NI; Cancer Pain and Palliative Medicine Service, Department of Medical Oncology, Shaare Zedek Medical Center, Jerusalem, Israel. Electronic address: chernyn@netvision.net.il.
Ann Oncol ; 34(9): 734-771, 2023 09.
Article em En | MEDLINE | ID: mdl-37343663
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma Folicular / Neoplasias Hematológicas / Neoplasias / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Áustria
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma Folicular / Neoplasias Hematológicas / Neoplasias / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Áustria